6-K/A 1 v426085_6ka.htm FORM 6-K/A

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K/A 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2015

Commission File Number: 001-34661

DEHAIER MEDICAL SYSTEMS LIMITED

Dehaier Medical Systems Limited

Room 501, 83 Fuxing Road

Haidian District, Beijing 100856

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x Form 40-F  ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Explanatory Note:

This current report is filed solely to attach the translation of the press release referred to in the Current Report filed on December 1, 2015 (SEC Accession No. 0001144204-15-068724), the original Chinese language version of which may be found at the following link: http://www.cninfo.com.cn/finalpage/2015-12-02/1201802187.PDF. The Registrant did not draft the press release and has provided the translation as a convenience to its investors.

The remainder of the December 1, 2015 Current Report on Form 6-K remains unchanged.

Exhibits

The following document is filed herewith:

Exhibit Number		Document
99.1		Translation of press release published by HangZhou Liaison Interactive Technology Co., Ltd, dated December 1, 2015.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DEHAIER MEDICAL SYSTEMS LIMITED
December 2, 2015	By:	/s/ Ping Chen
		Ping Chen
		Chief Executive Officer
		(Principal Executive Officer) and
		Duly Authorized Officer